Fresenius SE & Co KGaA - Company Profile

Powered by

All the data and insights you need on Fresenius SE & Co KGaA in one report.

$395 $295
Buy Report View Sample
  • Save hours of research time and resources with
    our up-to-date Fresenius SE & Co KGaA Strategy Report

  • Understand Fresenius SE & Co KGaA position in the market,
    performance and strategic initiatives.

  • Gain competitive edge and increase your
    chances of success

Back to companies

Fresenius SE & Co KGaA: Overview

Select Item

Related keylists

Fresenius SE & Co KGaA (Fresenius) is a global healthcare group that offers products and services for dialysis, hospitals, and outpatient treatment. It provides various dialysis services through its own clinics and sells products to other dialysis service providers. Its major products and services include machines for hemodialysis, acute dialysis and peritoneal dialysis; solutions for infusion therapy; dialysis care services; liver support therapy services; and provision projects and services for hospitals and other health care facilities. It also operates and manages acute care and post-acute care hospitals in Germany through Helios Kliniken Group. Fresenius conducts operations in Asia-Pacific, Europe, Africa and the Americas. The company is headquartered in Bad Homburg, Hessen, Germany.

 Gain a 360-degree view of Fresenius SE & Co KGaA and make more informed decisions for your business Gain a 360-degree view of Fresenius SE & Co KGaA and make more informed decisions for your business Find out more
Headquarters Germany
Address Else-Kroener Strasse 1, Bad Homburg, Hessen, 61352
Website www.fresenius.com
Telephone 49 6172 6080
No of Employees 193,865
Industry Medical Equipment
Ticker Symbol & Exchange FRE (ETR)
Revenue (2022) $24.1B 3.6% (2022 vs 2021)
EPS XYZ
Net Income (2022) XYZ -143.3% (2022 vs 2021)
Market Cap* $15.3B
Net Profit Margin (2023) XYZ -141.8% (2022 vs 2021)
* As of and is in US$
View Fresenius SE & Co KGaA financials
Gain access to our premium signals and make informed decisions for your business Gain access to our premium signals and make informed decisions for your business Find out more

Fresenius SE & Co KGaA premium industry data and analytics

40+

Medical Clinical Trials

A database of clinical trials planned, currently ongoing, completed, suspended, withdrawn, and terminated in countries around the world.

2

Medical Pipeline Products

A database of medical devices that are in the process to get approved for sale around the world. Devices that are in development, through to those in the approval process are included.

1

IT Services Contracts

Improve competitive bidding with insights into all publicly disclosed IT services contracts for Fresenius SE & Co KGaA (including IT outsourcing, business process outsourcing, systems integration & consulting and more).

1

ICT Spend & Tech Priorities

IT Client Prospector provides intelligence on Fresenius SE & Co KGaA’s likely spend across technology areas enabling you to understand the digital strategy.

Products and Services

Products Services Brands
Fresenius Medical Care: End-Stage Renal Disease-related treatments Actemra
Peritoneal Dialysis Cyclers End-Stage Renal Disease-related laboratory testing services RoActemra
Hemodialysis Machines Pharmacy services Granuflo
XYZ XYZ XYZ
XYZ XYZ XYZ
XYZ XYZ XYZ
Understand Fresenius SE & Co KGaA portfolio and identify potential areas for collaboration Understand Fresenius SE & Co KGaA portfolio and identify potential areas for collaboration Find out more

History

History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.

Year Event Description
2024 Contracts/Agreements In January, the company entered into an agreement to sell Vamed for US$653.6 million.
2023 New Products/Services In November, Fresenius Kabi launched Tyenne.
2023 Others In November, the company completed the deconsolidation of Fresenius Medical Care.
Dive into past operations, including product releases, deals, acquisitions & more Dive into past operations, including product releases, deals, acquisitions & more Find out more
Image for loader

Competitor Comparison

Key Parameters Fresenius SE & Co KGaA Baxter International Inc DaVita Inc Nipro Corp Geratherm Medical AG
Headquarters Germany United States of America United States of America Japan Germany
City Bad Homburg Deerfield Denver Settsu-Shi Geschwenda
State/Province Hessen Illinois Colorado Osaka Thuringen
No. of Employees 193,865 60,000 70,000 38,770 188
Entity Type Public Public Public Public Public
Benchmark the company against the market with exclusive information on key competitors Benchmark the company against the market with exclusive information on key competitors Find out more
Chart Financial activity with access to more key stats Chart Financial activity with access to more key stats Find out more
Executives
Name Position Board Since Age
Michael Sen Chairman; Chief Executive Officer Executive Board 2023 56
Sara Hennicken Chief Financial Officer Senior Management 2022 42
Michael Moser Head - Legal, Compliance, Risk Management, ESG, Human Resources, and Fresenius Vamed Senior Management 2023 47
Robert Moller Chief Executive Officer - Helios Health GmbH Senior Management 2023 -
Pierluigi Antonelli Chief Executive Officer - Fresenius Kabi Senior Management 2023 56
Non Dignissim Eros Proin vel Convallis 2024 XY
Non Dignissim Eros Proin vel Convallis 2024 XY
Non Dignissim Eros Proin vel Convallis 2024 XY
Gain insight into Fresenius SE & Co KGaA key executives to enhance your sales strategy Gain insight into Fresenius SE & Co KGaA key executives to enhance your sales strategy Find out more
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer

Get in touch about GlobalData Company reports

Contact the team or request a demo to find out how our data can drive your business forward